The Latest Breaking News from Eli Lilly

The S&P 500 Index ($SPX ) (SPY ) today is up +1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +2.24%. US stocks are trading higher today after US weekly initial unemployment claims fell more...

Eli Lilly stock is surging after the pharma giant beat Q2 estimates and lifted its full-year outlook. Here's what you need to know.

Danish company, which also makes Ozempic, faces increasing competition from US rival Eli Lilly

Down 96% from all-time highs, AbCellera Biologics is a biotech stock with massive upside potential, given consensus price target estimates.

The S&P 500 is down "only" 8.2% since its July 16 high. So why does the drop feel so bad?

Recession fears are gripping the market. Warren Buffett's Berkshire halved its Apple stake. Nvidia reportedly has delayed its next AI chip.

Tirzepatide, a drug for diabetes and obesity, has sent the 148-year-old pharma giant on a wild ride. It’s now the ninth most valuable company in the world.

Their strong fundamentals, brand strength, and drive to succeed could propel their stock higher.

The pharmaceutical industry’s long-term growth is fueled by a surge in demand for personalized medicine, rising R&D initiatives, and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid pharma stocks, Eli Lilly (LLY), Bristol-Myers (BMY), and Merck & Co. (MRK), which look poised for blockbuster…